🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thank you Neeraj Agarwal, MD, FASCO for highlighting the results of STELLAR-002 in ccRCC Moffitt Cancer Center Moffitt Research ASCO #ASCO25

Ashish M. Kamat, MD, MBBS Vedang Murthy gaganprakash IBCG Shilpa Gupta Neeraj Agarwal, MD, FASCO Sumanta K. Pal, MD, FASCO UroToday.com DrBagrodia World Bladder Cancer Patient Coalition Jaspreet Sandhu Sewanti Limaye 🇮🇳🇺🇸 Philippe spiess Great to see. Really enjoying this global learning! In a World that seems increasingly broken, these are the types of meetings that give real hope

Congratulations Jay and you truly did an exceptional job! Such a great leader who does it with vision, collegiality, and a steadfast commitment to excellence! 👏👏👏

Philippe spiess 🙏 gratitude for all of your contributions and leadership on the core curriculum and now the update series.

Congrats Jad! So incredibly proud of you 👏 👏👏

#ASCO25 Day2️⃣ #UpperTractUrothelialCarcinoma ENLIGHTED phase 3 study #VitalyMargulis ✔️Low grade UTUC is not a letal disease 👉 Unmet need for organ-sparing options ✨Padeliporfin Vascular Targeted Photodynamic therapy (VTP) ❗️Overall Response rate: 86,5% ❗️Complete response:

#ASCO25 Day2️⃣ #BladderCancer #MIBC SURE-02 - Ph2 Neoadj Sacituzumab govitecan (SG) + Pembro in MIBC => Response-adapted bladder sparing and Adj Pembro Andrea Necchi ▶️44% cCR rate ▶️RC refusal 👉bladder preservation without Chemo RT in 74%MIBC OncoAlert MEDTRACK

Following his oral presentation at #ASCO25, Jad Chahoud, MD (jc) summarizes results from the STELLAR-002 expansion cohort. Zanzalintinib + nivolumab ± relatlimab shows promising early activity in previously untreated ccRCC. Read more: meetings.asco.org/2025-asco-annu…

So incredibly proud of you, Jad. The very best GU medical oncologist who is brilliant, dedicated, compassionate, and always striving to improve the outcomes for our patients. Congratulations my brother! 🥂👏😊

Impressive Tru 👍

Congrats Meghan! So incredibly proud and what an excellent choice by the AUA in your selection! 👏👏👏

In this original research, the authors investigated the relationship between Google search trends for #erectile #dysfunction and a variety of factors across the United States. 🔗to Full Article: mdpi.com/3272788 📜Latest Issue: mdpi.com/2563-6499/6/2?… SIU-Urology

The International Bladder Cancer Group (IBCG) is pleased to announce the #IBCG2025 Travel Award, designed to support outstanding fellows and early-career academic faculty who are committed to advancing the field of bladder cancer. For more information and to apply:

"Outcomes of PeIN at the surgical margin: insights from an organ-sparing penile cancer database". Highly clinically relevant question I am often asked about in terms of management. ncbi.nlm.nih.gov/pubmed/40478443

Squamous cell carcinoma of unknown primary (SCCUP): a genomic landscape study - ScienceDirect sciencedirect.com/science/articl…

The Moffitt Neuro Onc group truly rocks! 👍👏

Great message and fully agree Vivek! 👏👍

Computational Histology Artificial Intelligence (CHAI) Enhances Risk Stratification of High-grade Ta NMIBC in a Multicenter Cohort: Comparison to Current European Association of Urology and American Urological Association Stratification Models sciencedirect.com/science/articl…

Felicitation Karima! 👏👏👏

Caring for her father sparked Tanaz Nekouee’s dream to become a doctor. He was initially diagnosed with multiple sclerosis after experiencing years of progressive weakness. But a deeper look by experts at Moffitt Cancer Center revealed the true cause, a rare spinal cord tumor